Susquehanna Portfolio Strategies’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Susquehanna Portfolio Strategies's DXCM Position: Q2 2026 in Review
Susquehanna Portfolio Strategies increased its DexCom (DXCM) stake by 16% in Q2 2026, buying an estimated $5.77M and bringing the position to 612,127 shares worth $41.2M. The position accounts for 0.66% of the portfolio, ranked #32.
Susquehanna Portfolio Strategies first reported a position in DXCM in Q2 2025 and has held it in 4 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Susquehanna Portfolio Strategies held 612,127 shares of DexCom worth $41.2M as of Q2 2026.
- Susquehanna Portfolio Strategies bought 86,550 DexCom shares in Q2 2026, an estimated $5.77M.
- DexCom made up 0.66% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #32 holding.
- Susquehanna Portfolio Strategies first reported a position in DexCom in Q2 2025 and has held it in 4 quarters since.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.